BlackRock’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-3,736,334
| Closed | -$19.3M | – | 5098 |
|
|
2019
Q2 | $19.3M | Buy |
3,736,334
+213,530
| +6% | +$1.1M | ﹤0.01% | 2834 |
|
|
2019
Q1 | $12.7M | Sell |
3,522,804
-106,791
| -3% | -$384K | ﹤0.01% | 2974 |
|
|
2018
Q4 | $22.2M | Buy |
3,629,595
+190,011
| +6% | +$1.16M | ﹤0.01% | 2666 |
|
|
2018
Q3 | $20.1M | Buy |
3,439,584
+91,344
| +3% | +$533K | ﹤0.01% | 2845 |
|
|
2018
Q2 | $14.2M | Buy |
3,348,240
+345,204
| +11% | +$1.47M | ﹤0.01% | 3032 |
|
|
2018
Q1 | $13.2M | Sell |
3,003,036
-61,079
| -2% | -$269K | ﹤0.01% | 2958 |
|
|
2017
Q4 | $16.1M | Sell |
3,064,115
-49,754
| -2% | -$262K | ﹤0.01% | 2867 |
|
|
2017
Q3 | $19.1M | Buy |
3,113,869
+118,579
| +4% | +$727K | ﹤0.01% | 2801 |
|
|
2017
Q2 | $21.7M | Buy |
2,995,290
+346,189
| +13% | +$2.5M | ﹤0.01% | 2726 |
|
|
2017
Q1 | $14M | Buy |
2,649,101
+2,645,880
| +82,145% | +$14M | ﹤0.01% | 2936 |
|
|
2016
Q4 | $23K | Sell |
3,221
-558
| -15% | -$3.98K | ﹤0.01% | 3160 |
|
|
2016
Q3 | $35K | Buy |
3,779
+469
| +14% | +$4.34K | ﹤0.01% | 3059 |
|
|
2016
Q2 | $21K | Buy |
3,310
+1,470
| +80% | +$9.33K | ﹤0.01% | 3219 |
|
|
2016
Q1 | $11K | Buy |
1,840
+1,194
| +185% | +$7.14K | ﹤0.01% | 3081 |
|
|
2015
Q4 | $4K | Hold |
646
| – | – | ﹤0.01% | 3190 |
|
|
2015
Q3 | $5K | Hold |
646
| – | – | ﹤0.01% | 3013 |
|
|
2015
Q2 | $10K | Sell |
646
-116
| -15% | -$1.8K | ﹤0.01% | 2770 |
|
|
2015
Q1 | $12K | Hold |
762
| – | – | ﹤0.01% | 2617 |
|
|
2014
Q4 | $14K | Hold |
762
| – | – | ﹤0.01% | 2543 |
|
|
2014
Q3 | $8K | Buy |
762
+158
| +26% | +$1.66K | ﹤0.01% | 2842 |
|
|
2014
Q2 | $9K | Buy |
+604
| New | +$9K | ﹤0.01% | 2832 |
|